INSTRUCTIONS TO PATIENT Explain to the patient the purpose of test and the need for a blood sample...

28
INSTRUCTIONS TO PATIENT Explain to the patient the purpose of test and the need for a blood sample to be drawn. No fasting is required before the test.

Transcript of INSTRUCTIONS TO PATIENT Explain to the patient the purpose of test and the need for a blood sample...

Page 1: INSTRUCTIONS TO PATIENT  Explain to the patient the purpose of test and the need for a blood sample to be drawn.  No fasting is required before the test.

INSTRUCTIONS TO PATIENT

Explain to the patient the purpose of test and the need for a blood sample to be drawn.

No fasting is required before the test.

Page 2: INSTRUCTIONS TO PATIENT  Explain to the patient the purpose of test and the need for a blood sample to be drawn.  No fasting is required before the test.

PROCEDURE

A 3-5-ml blood sample is drawn through a vene puncture to a sodium floride oxalate tube.

Gloves are worn throughout the procedure

Apply pressure at Venopuncture site to arrest bleeding

Label the sample and transport to the Lab.

Page 3: INSTRUCTIONS TO PATIENT  Explain to the patient the purpose of test and the need for a blood sample to be drawn.  No fasting is required before the test.

VALUE OF TEST To determine the degree of glucose control. Screening for DM. Distinguishing chemical forms from overt

Diabetes. Determining the relationship between

chronic high blood sugar level and pathological complications of DM.

Evaluating the efficiency of diabetic therapy.

Managing DM in Pregnancy.

Page 4: INSTRUCTIONS TO PATIENT  Explain to the patient the purpose of test and the need for a blood sample to be drawn.  No fasting is required before the test.

PRINCIPLE OF GLYCATION Glycation of protein is a frequent

occurrence, but in the case of haemoglobin, a non-enzymatic seaction occurs betweeen glucose and N-end of the beta-chain. This form a Schiff base which is itself conserted to 1- deoxyfructose. This rearrangement is an example of an Amadori rearrangement.

Page 5: INSTRUCTIONS TO PATIENT  Explain to the patient the purpose of test and the need for a blood sample to be drawn.  No fasting is required before the test.

CONTD.

When blood glucose levels are high, glucose

molecules attach to the Hb in red blood

cells. The longer hyperglycemia occurs in

blood, the more glucose binds to Hb in the

red blood cells and the higher the gycated

haemoglobin.

Page 6: INSTRUCTIONS TO PATIENT  Explain to the patient the purpose of test and the need for a blood sample to be drawn.  No fasting is required before the test.

CONTD.

Once a haemoglobin molecule is glycated, it remains that way. A build-up of HbA1c WITHIN the red cell, therefore, reflects the average level of glucose to which the cell has been exposed during its life-cycle. Measuring HbA1c assesses the effectiveness of therapy by monitoring long-term serum glucose regulation.

Page 7: INSTRUCTIONS TO PATIENT  Explain to the patient the purpose of test and the need for a blood sample to be drawn.  No fasting is required before the test.

LIMITATION

Although HbA1c levels are reliable indication

of recent average glycaemic control, it does

not provide information about the daily

pattern of blood glucose levels, Therefore

information required for logical adjustment of

insulin doses is derived from Routine RBS, FBS

test

Page 8: INSTRUCTIONS TO PATIENT  Explain to the patient the purpose of test and the need for a blood sample to be drawn.  No fasting is required before the test.

CONTD.

More recent changes in glycaemia

(ie. Within the preceding 4-weeks or

so) will influence HbA1c level more

than glucose 12 or more weeks ago.

Page 9: INSTRUCTIONS TO PATIENT  Explain to the patient the purpose of test and the need for a blood sample to be drawn.  No fasting is required before the test.

METHODS OF ESTIMATION

1. High performance liquid chromatography (HPLC): The HbA1c result is calculated as a ratio to total Hb by using a chromatogram

2. Radiolmmunoassays3. Enzymrimmuno assays4. Isoelectric to focusing5. Colorimetric method6. Microcoleum ion exchange technique7. Capillary electrophoresis8. Boronate afinity chromatography.

Page 10: INSTRUCTIONS TO PATIENT  Explain to the patient the purpose of test and the need for a blood sample to be drawn.  No fasting is required before the test.

ADVANTANGES AND DISADVANTAGES OF VARIOUS ASSAY METHODS

ASSAY PRINCIPLE ADVANTAGES DISADVANTAGES

Ion Exchange Chromatography

HbA1c has lower isoelectric point and migrate faster than other Hb Componets

Can inspect chromograms for Hb Variants measurement with great precision

Variable interference from the Haemoglobinopatheis, HbF and Carbamylated Hb but the current ion in exchange assays correct for HbF & carbonlated Hb does not interfere.

Page 11: INSTRUCTIONS TO PATIENT  Explain to the patient the purpose of test and the need for a blood sample to be drawn.  No fasting is required before the test.

contd

Boronate affinity

Glucose binds to m-aminophemlborononic acid

Minimal Interference from Haemoglobinopatheis, HbF and Carbamylated Hb.

Measures not only glucation of N-terminal valine on B chain but also B-chains glycated at other sites and glycated Alpha-chain.

Page 12: INSTRUCTIONS TO PATIENT  Explain to the patient the purpose of test and the need for a blood sample to be drawn.  No fasting is required before the test.

contd

Immunoassays Antibody binds to glucose and between 4-10 N-terminal amino acids on b-chain.

Not affected by HbE, Hb D, or carbamylated Hb, Relatively easy to implement under many different format.

May be affected by haemoglonopatheis with altered amino acids or binding sites. Some Interferes with HbF

Page 13: INSTRUCTIONS TO PATIENT  Explain to the patient the purpose of test and the need for a blood sample to be drawn.  No fasting is required before the test.

PRINCIPLES & PROCEDURES

Using kit of HbA1c. A haemolysed preparation of whole

blood is mixed continously for 5 minutes with a weak binding caton-exchange resin during this time the non-glycated haemoglobin, which consist of the bulk of the haemoglobin (HbAo) binds to the resin. After the mixing period a filter is used to separate the supernatant containing the

Page 14: INSTRUCTIONS TO PATIENT  Explain to the patient the purpose of test and the need for a blood sample to be drawn.  No fasting is required before the test.

CONTD.

Glycohaemoglobin from the resin. The percent glycohaemoglobin is determine by measuring the absorbance at 415 nm (405 -420 nm acceptable) of the glycohaemoglobin fraction and the total haemoglobin fraction. The ration of the two absorbances gives the percent haemoglobin.

Page 15: INSTRUCTIONS TO PATIENT  Explain to the patient the purpose of test and the need for a blood sample to be drawn.  No fasting is required before the test.

CONTD.

Using Ghb analyser. It uses low pressure cation exchange

chromatography in conjuction with gradient elution to separate human haemoglobin subtype and variants from haemolysed whole blood. The separated haemoglobin fraction are monitored by means of absorption of light at 415mn the chromatogram obtained is recorded

Page 16: INSTRUCTIONS TO PATIENT  Explain to the patient the purpose of test and the need for a blood sample to be drawn.  No fasting is required before the test.

CONTD.

And stored by the on board computer. The analyser performs the analysis of the chromatogram and generate a printed report.

Page 17: INSTRUCTIONS TO PATIENT  Explain to the patient the purpose of test and the need for a blood sample to be drawn.  No fasting is required before the test.

FACTORS THAT AFFECTS THE TEST RESULT

INCREASE DECREASE

Increase in HbF ↑

Haemolysis/bleeding

Haemoglobinopatheis (HbS) Glucose -6- Pphosphate dehydrogenase deficency

Invalid result

Page 18: INSTRUCTIONS TO PATIENT  Explain to the patient the purpose of test and the need for a blood sample to be drawn.  No fasting is required before the test.

contdSurgery, anaemia, blood transfusion, high erythrocyte turnover

Invalid Result

Liver disease ↓

Blood donation ↑

Vit B12 folate deficiency (longer rbc infespan)

Page 19: INSTRUCTIONS TO PATIENT  Explain to the patient the purpose of test and the need for a blood sample to be drawn.  No fasting is required before the test.

contd

Splenectomy (Increase rbc life-span)

Pregnancy (Hormonal changes)

Renal failure(dialysis)

Page 20: INSTRUCTIONS TO PATIENT  Explain to the patient the purpose of test and the need for a blood sample to be drawn.  No fasting is required before the test.

ESTIMATED AVERAGE GLUCOSE (EAG) This term is used to understand the

approximate relationship between HbA1c and glucose Concentration.

Formular: eAG (mg/dl)=(28.7xHbA1c)-46.7

eAG (mmollL) = (1.59 x HbA1c) – 2.59

Page 21: INSTRUCTIONS TO PATIENT  Explain to the patient the purpose of test and the need for a blood sample to be drawn.  No fasting is required before the test.

NORMAL RANGE:

Varies with different Lab but the reference laboratory value is:-

Non-diabetic adult – 2.2-5.0%Diabetic adult: 7% (ADA guideline).

Page 22: INSTRUCTIONS TO PATIENT  Explain to the patient the purpose of test and the need for a blood sample to be drawn.  No fasting is required before the test.

RESULT INTERPRETATIONPossible meaning of Abnormal result

INCREASE DECREASE

Alcohol Chronic loss of blood

Hyperghycemia Chronic renal failure

Lead poisioning Haemolytic Anaemia

Newly diagnose DM Sickle-cell anaemia

Page 23: INSTRUCTIONS TO PATIENT  Explain to the patient the purpose of test and the need for a blood sample to be drawn.  No fasting is required before the test.

contd

Poor DM control Thalassemia

Pregnancy

Page 24: INSTRUCTIONS TO PATIENT  Explain to the patient the purpose of test and the need for a blood sample to be drawn.  No fasting is required before the test.

RECOMMENDATIONS

Management goals should be aimed at preventing the

development of these complications and/or delaying the

onset of these complications for a prolonged or healthy life,

therefore a test of this nature (HbA1c) is highly

recommended for adequate management control of DM.

It should be performed at least twice a year in patients who

are meeting treatment goal and who have stable glycerinic

control.

Page 25: INSTRUCTIONS TO PATIENT  Explain to the patient the purpose of test and the need for a blood sample to be drawn.  No fasting is required before the test.

CONTD.

Quarterly in patient whose therapy has changed or who are not meeting glycemic goals.

As needed to assist with decision-making on therapy changes.

Glycernic goals should be individualized, more stringent value ( less than 6%) reduce complications.

.

Page 26: INSTRUCTIONS TO PATIENT  Explain to the patient the purpose of test and the need for a blood sample to be drawn.  No fasting is required before the test.

CONCLUSION Diabetes is now affecting many in

the work place, it has a major and deleterious impact on both individual and national productivity. The socio-economic consequences of diabetes and its complications could have a seriously negative impact in the economics of developed and developing nation.

Page 27: INSTRUCTIONS TO PATIENT  Explain to the patient the purpose of test and the need for a blood sample to be drawn.  No fasting is required before the test.

CONTD. DM is a world health Challenge and

the complications such as Retinopathy, neuropathy,Nephropathy, Skin lesions (ulcer), diabetic Keto acidosis can be life threatening and difficult to reverse .

Page 28: INSTRUCTIONS TO PATIENT  Explain to the patient the purpose of test and the need for a blood sample to be drawn.  No fasting is required before the test.

REFERENCES:

Oxford hand book of clinical and Laboratory Investigations by Drew Provan & Andrew Krentz (2002).

McGraw-Hills Manual of Laboratory & Diagnostic test (Denis D. Willson 1976).

Blacks Medical Dictionary 41st Edition (2005) Huisman T.H , Mantis E.A Dozy A (1958) Chromatography of Haemoglobin types on

Carbozymethylcellulose. Clin. Med. 52 (2): 312 -327 Koenig R.J , Peterson C.M, Jones R.L,( et al 1976 )

“Correlation of glucose regulation and Haemoglobin A1c in diabetes mellitus” N.Engl. J. Med. 295 (8): 417 -420.